TGF-β and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells

作者: Lyudmila A. Lyakh , Michael Sanford , Sebel Chekol , Howard A. Young , Anita B. Roberts

DOI: 10.4049/JIMMUNOL.174.4.2061

关键词:

摘要: We previously demonstrated that agents known to signal infection or inflammation can rapidly and directly drive differentiation of human CD14+ monocytes into CD83+ dendritic cells (DCs) when introduced under serum-free conditions. In this study, we evaluated the effects TGF-beta vitamin D3 (VitD3) on proportion function adopt DC characteristics. significantly decreased adopted stable characteristics in response LPS, but had little no effect calcium ionophore-induced differentiation. contrast, VitD3 showed such pathway specificity dramatically suppressed DCs these agents. Both altered cytokine chemokine production LPS-treated monocytes, inhibited IL-12 IL-10 secretion, functional capacity DCs. Despite similar VitD3, there are significant differences signaling pathways used by agents, as evidenced their distinct LPS- differentiation, LPS-induced secretion IL-10, two members NF-kappaB family transcription factors, RelB cRel. These studies identify potent regulatory factors use suppress both well secrete Th1-polarizing IL-12. Because present serum negatively affect at physiological concentrations, our findings likely have significance regarding vivo role determining type immune responses.

参考文章(81)
Gary K. Koski, Gretchen N. Schwartz, David E. Weng, Ronald E. Gress, Friederike H.C. Engels, Maria Tsokos, Brian J. Czerniecki, Peter A. Cohen, Calcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood. ,vol. 94, pp. 1359- 1371 ,(1999) , 10.1182/BLOOD.V94.4.1359
Teresa A. Borkowski, John J. Letterio, Crystal L. Mackall, Atsushi Saitoh, Andrew G. Farr, Xiao-Jing Wang, Dennis R. Roop, Ronald E. Gress, Mark C. Udey, Langerhans Cells in the TGFβ1 Null Mouse Advances in Experimental Medicine and Biology. ,vol. 417, pp. 307- 310 ,(1997) , 10.1007/978-1-4757-9966-8_50
John Y. Kao, Yusong Gong, Chuan-Min Chen, Qiong-Duan Zheng, Jian-Jun Chen, Tumor-Derived TGF-β Reduces the Efficacy of Dendritic Cell/Tumor Fusion Vaccine Journal of Immunology. ,vol. 170, pp. 3806- 3811 ,(2003) , 10.4049/JIMMUNOL.170.7.3806
Jeffrey L Wrana, Liliana Attisano, Rotraud Wieser, Francesc Ventura, Joan Massagué, None, Mechanism of activation of the TGF-β receptor Nature. ,vol. 370, pp. 341- 347 ,(1994) , 10.1038/370341A0
Brian J. Czerniecki, Licia Rivoltini, James G. Roros, Yasmine M. Hijazi, Steven A. Rosenberg, Shuwen Xu, Charles Carter, Gary K. Koski, Peter A. Cohen, David E. Weng, Hyun I. Kim, Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. Journal of Immunology. ,vol. 159, pp. 3823- 3837 ,(1997)
Jean-François Arrighi, Michela Rebsamen, Françoise Rousset, Vincent Kindler, Conrad Hauser, A Critical Role for p38 Mitogen-Activated Protein Kinase in the Maturation of Human Blood-Derived Dendritic Cells Induced by Lipopolysaccharide, TNF-α, and Contact Sensitizers Journal of Immunology. ,vol. 166, pp. 3837- 3845 ,(2001) , 10.4049/JIMMUNOL.166.6.3837
Leonid Gorelik, Richard A. Flavell, Transforming growth factor-β in T-cell biology Nature Reviews Immunology. ,vol. 2, pp. 46- 53 ,(2002) , 10.1038/NRI704
Sebastian Amigorena, Nicole Brousse, Frederic Geissmann, Patrick Revy, Anne Durandy, Armelle Regnault, Michel Dy, Yves Lepelletier, Olivier Hermine, TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. Journal of Immunology. ,vol. 162, pp. 4567- 4575 ,(1999)